ARDELYX

Ardelyx develops novel, first-in-class oral therapeutics to correct mineral metabolism and metabolic disorders. The Company's molecules, whose systemic exposure is severely restricted, target transporters and receptors, modulating the uptake of nutrients or inducing secretion of key hormones to produce a therapeutic benefit in patients. The Company's non-systemic products act from within the intestines to avoid potential side effects that could occur with systemic exposure. The Company's lead pr... oduct, RDX5791, a minimally-absorbed, orally administered NHE3 sodium transport inhibitor, is being developed both for constipation-predominant irritable bowel syndrome (IBS-C) and for prevention of excess dietary sodium absorption, a new treatment modality for high blood pressure. RDX5791 is in phase 2 for IBS-C and a dose-ranging/regimen study for inhibition of excess dietary sodium absorption. Ardelyx is also developing RDX002, a minimally-absorbed, orally administered NaP2b phosphate transport inhibitor for the inhibition of phosphate absorption in patients with chronic kidney disease, and RDX009, a minimally-absorbed, orally administered TGR5 agonist for the treatment of type 2 diabetes through direct induction of intestinal incretins such as GLP-1 and PYY. Both RDX002 and RDX009 are in preclinical development. To date, Ardelyx has raised $56M in venture and angel funding since it was founded in 2007. Ardelyx is located in Fremont, California.

#SimilarOrganizations #People #Financial #Event #Website #More

ARDELYX

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Medical

Founded:

2007-01-01

Address:

Fremont, California, United States

Country:

United States

Website Url:

http://www.ardelyx.com

Total Employee:

101+

Status:

Active

Contact:

510) 745-1700

Email Addresses:

[email protected]

Total Funding:

346.38 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics

Similar Organizations

c4-therapeutics-logo

C4 Therapeutics

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

entrada-therapeutics-logo

Entrada Therapeutics

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

hebecell-logo

HebeCell

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.

neumora-therapeutics-logo

Neumora Therapeutics

Neumora Therapeutics operates as a clinical-stage biotechnology company.

praxis-precision-medicines-logo

Praxis Precision Medicines

Praxis Precision Medicines offers drug development services.

viking-therapeutics-logo

Viking Therapeutics

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

Current Advisors List

david-mott_image

David Mott Board Member @ Ardelyx
Board_member

jean-fréchet_image

Jean Fréchet Board of Directors @ Ardelyx
Board_member

Current Employees Featured

david-rosenbaum_image

David Rosenbaum
David Rosenbaum SVP, Drug Development & CDO @ Ardelyx
SVP, Drug Development & CDO
2009-01-01

peter-g-schultz_image

Peter G. Schultz
Peter G. Schultz Co-Founder and Director @ Ardelyx
Co-Founder and Director

andrew-spencer_image

Andrew Spencer
Andrew Spencer Senior Director, R&D Alliance Management @ Ardelyx
Senior Director, R&D Alliance Management

jeff-jacobs_image

Jeff Jacobs
Jeff Jacobs Chief Scientific Officer & Sr. Vice-President of Technical Operations @ Ardelyx
Chief Scientific Officer & Sr. Vice-President of Technical Operations
2020-01-01

robert-blanks_image

Robert Blanks
Robert Blanks Chief Regulatory Affairs and Quality Assurance Officer @ Ardelyx
Chief Regulatory Affairs and Quality Assurance Officer
2020-01-01

susan-rodriguez_image

Susan Rodriguez
Susan Rodriguez Chief Commercial Officer @ Ardelyx
Chief Commercial Officer
2020-05-01

not_available_image

Dominique Charmot
Dominique Charmot Chief Scientific Officer &Board of Directors @ Ardelyx
Chief Scientific Officer &Board of Directors

elizabeth-grammer_image

Elizabeth Grammer
Elizabeth Grammer Chief Legal and Administrative Officer @ Ardelyx
Chief Legal and Administrative Officer
2020-01-01

mike-raab_image

Mike Raab
Mike Raab CEO & President @ Ardelyx
CEO & President

david-collier_image

David Collier
David Collier Director @ Ardelyx
Director

Founder

not_available_image

Dominique Charmot

peter-g-schultz_image

Peter G. Schultz

Stock Details

Company's stock symbol is NASDAQ:ARDX

Investors List

kyowa-hakko-kirin_image

Key Employee Changes

Date	New article
2020-06-08	Ardelyx Appoints Veteran Biopharma Executive, Justin Renz, as Chief Financial Officer
2020-05-18	Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer

Official Site Inspections

http://www.ardelyx.com Semrush global rank: 2.28 M Semrush visits lastest month: 8.27 K

Host Informations
Whois Informations

Loading ...